A recent study utilized the protein and gene expression of KIF2C and RAC1 in HCC tissue to characterize a specific HCC patient subtype, which significantly correlated with worse prognosis, clinicopathological grade, increased tumor mutation burden, higher CD8+ T cell infiltration and an altered chemotherapy drug sensitivity [156]. This evidence concerns the gene RAC1 and hepatocellular carcinoma.